Related Experiment Video
Updated: May 2, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation
Cinzia Puppin1, Cosimo Durante, Marialuisa Sponziello
1Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Piazzale Kolbe 4, 33100, Udine, Italy.
Abstract:
Abnormal expression of non-coding micro RNA (miRNA) has been described in medullary thyroid carcinoma (MTC). Expression of genes encoding factors involved in miRNA biogenesis results often deregulated in human cancer and correlates with aggressive clinical behavior. In this study, expression of four genes involved in miRNA biogenesis (DICER, DROSHA, DCGR8, and XPO5) was investigated in 54 specimens of MTC. Among them, 33 and 13 harbored RET and RAS mutations, respectively. DICER, DGCR8, and XPO5 mRNA levels were significantly overexpressed in MTC harboring RET mutations, in particular, in the presence of RET634 mutation. When MTCs with RET and RAS mutations were compared, only DGCR8 displayed a significant difference, while MTCs with RAS mutations did not show significant differences with respect to non-mutated tumors. We then attempted to correlate expression of miRNA biogenesis genes with tumor aggressiveness. According to the TNM status, MTCs were divided in two groups and compared (N0 M0 vs. N1 and/or M1): for all four genes no significant difference was detected. Cell line experiments, in which expression of a RET mutation is silenced by siRNA, suggest the existence of a causal relationship between RET mutation and overexpression of DICER, DGCR8, and XPO5 genes. These findings demonstrate that RET- but not RAS-driven tumorigenic alterations include abnormalities in the expression of some important genes involved in miRNA biogenesis that could represent new potential markers for targeted therapies in the treatment of RET-mutated MTCs aimed to restore the normal miRNA expression profile.
Insights
RET mutations in medullary thyroid carcinoma (MTC) are linked to altered expression of microRNA (miRNA) biogenesis genes, unlike RAS mutations. This suggests potential therapeutic targets for RET-driven MTC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Abnormal microRNA (miRNA) expression is implicated in medullary thyroid carcinoma (MTC).
- Deregulation of miRNA biogenesis genes is observed in various human cancers, correlating with disease progression.
Purpose of the Study:
- To investigate the expression of key miRNA biogenesis genes (DICER, DROSHA, DGCR8, XPO5) in MTC specimens.
- To determine the correlation between the expression of these genes and specific genetic mutations (RET, RAS) and tumor aggressiveness.
Main Methods:
- Analysis of DICER, DROSHA, DGCR8, and XPO5 mRNA levels in 54 MTC specimens.
- Correlation of gene expression with RET and RAS mutation status and TNM staging.
- In vitro experiments using siRNA to silence RET mutations in cell lines.
Main Results:
- DICER, DGCR8, and XPO5 were significantly overexpressed in MTCs with RET mutations, especially RET634.
- DGCR8 showed a significant difference between RET and RAS mutated MTCs.
- No significant correlation was found between miRNA biogenesis gene expression and tumor aggressiveness (TNM status).
- Cell line experiments indicated a causal link between RET mutation and overexpression of DICER, DGCR8, and XPO5.
Conclusions:
- RET mutations, but not RAS mutations, in MTC are associated with dysregulated expression of miRNA biogenesis genes.
- These findings highlight potential novel therapeutic targets for RET-mutated MTC aimed at normalizing miRNA expression.
Related Concept Videos
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

